These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 29084079

  • 1. Real-world Experience of Anti-tumor Necrosis Factor Therapy for Internal Fistulas in Crohn's Disease: A Retrospective Multicenter Cohort Study.
    Kobayashi T, Hishida A, Tanaka H, Nuki Y, Bamba S, Yamada A, Fujii T, Shinzaki S, Yokoyama Y, Yoshida A, Ozeki K, Ashizuka S, Kamata N, Nanjo S, Kakimoto K, Nakamura M, Matsui A, Yamauchi R, Takahashi S, Tomizawa T, Yoshino T, Hibi T.
    Inflamm Bowel Dis; 2017 Dec; 23(12):2245-2251. PubMed ID: 29084079
    [Abstract] [Full Text] [Related]

  • 2. Anti-TNF therapy for genital fistulas in female patients with Crohn's disease: a nationwide study from the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID).
    Le Baut G, Peyrin-Biroulet L, Bouguen G, Gornet JM, Stefanescu C, Amiot A, Laharie D, Altwegg R, Fumery M, Trang C, Vuitton L, Simon M, Gilletta de Saint Joseph C, Nahon S, Caillo L, Del Tedesco E, Plastaras L, Aubourg A, Pineton de Chambrun G, Seksik P, Viennot S.
    Aliment Pharmacol Ther; 2018 Oct; 48(8):831-838. PubMed ID: 30194687
    [Abstract] [Full Text] [Related]

  • 3. Outcomes of Medical and Surgical Therapy for Entero-urinary Fistulas in Crohn's Disease.
    Taxonera C, Barreiro-de-Acosta M, Bastida G, Martinez-Gonzalez J, Merino O, García-Sánchez V, Gisbert JP, Marín-Jiménez I, López-Serrano P, Gómez-García M, Iglesias E, Lopez-Sanroman A, Chaparro M, Saro C, Bermejo F, Pérez-Carazo L, Plaza R, Olivares D, Alba C, Mendoza JL, Fernández-Blanco I.
    J Crohns Colitis; 2016 Jun; 10(6):657-62. PubMed ID: 26786982
    [Abstract] [Full Text] [Related]

  • 4. Treatment of perianal fistula in Crohn's disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment.
    de Groof EJ, Sahami S, Lucas C, Ponsioen CY, Bemelman WA, Buskens CJ.
    Colorectal Dis; 2016 Jul; 18(7):667-75. PubMed ID: 26921847
    [Abstract] [Full Text] [Related]

  • 5. Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients.
    Strik AS, Löwenberg M, Buskens CJ, B Gecse K, I Ponsioen C, Bemelman WA, D'Haens GR.
    Scand J Gastroenterol; 2019 Apr; 54(4):453-458. PubMed ID: 31032686
    [Abstract] [Full Text] [Related]

  • 6. Anti-TNF Therapy Within 2 Years of Crohn's Disease Diagnosis Improves Patient Outcomes: A Retrospective Cohort Study.
    Ma C, Beilman CL, Huang VW, Fedorak DK, Kroeker KI, Dieleman LA, Halloran BP, Fedorak RN.
    Inflamm Bowel Dis; 2016 Apr; 22(4):870-9. PubMed ID: 26818419
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of tumour necrosis factor antagonists in stricturing Crohn's disease: A tertiary center real-life experience.
    Allocca M, Bonifacio C, Fiorino G, Spinelli A, Furfaro F, Balzarini L, Bonovas S, Danese S.
    Dig Liver Dis; 2017 Aug; 49(8):872-877. PubMed ID: 28416240
    [Abstract] [Full Text] [Related]

  • 8. [Efficacy of tumor necrosis factor-alpha inhibitors in fistulising perianal Crohn's disease].
    Bor R, Farkas K, Bálint A, Szűcs M, Abrahám S, Baradnay G, Wittmann T, Szepes Z, Nagy F, Molnár T.
    Orv Hetil; 2013 Dec 08; 154(49):1943-8. PubMed ID: 24292112
    [Abstract] [Full Text] [Related]

  • 9. Genital fistulas in female Crohn's disease patients.: clinical characteristics and response to therapy.
    de la Poza G, López-Sanroman A, Taxonera C, Marín-Jimenez I, Gisbert JP, Bermejo F, Opio V, Muriel A.
    J Crohns Colitis; 2012 Apr 08; 6(3):276-80. PubMed ID: 22405162
    [Abstract] [Full Text] [Related]

  • 10. Tumor Necrosis Factor Inhibitors May Have Limited Efficacy for Complex Perianal Fistulas Without Luminal Crohn's Disease.
    McCurdy JD, Parlow S, Dawkins Y, Samji K, Rhee GG, Oliveira L, Macdonald B, Sabri E, Murthy S.
    Dig Dis Sci; 2020 Jun 08; 65(6):1784-1789. PubMed ID: 31642006
    [Abstract] [Full Text] [Related]

  • 11. Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease.
    Thomassin L, Armengol-Debeir L, Charpentier C, Bridoux V, Koning E, Savoye G, Savoye-Collet C.
    World J Gastroenterol; 2017 Jun 21; 23(23):4285-4292. PubMed ID: 28694669
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
    Bouguen G, Siproudhis L, Gizard E, Wallenhorst T, Billioud V, Bretagne JF, Bigard MA, Peyrin-Biroulet L.
    Clin Gastroenterol Hepatol; 2013 Aug 21; 11(8):975-81.e1-4. PubMed ID: 23376316
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn's Disease.
    Bouguen G, Huguet A, Amiot A, Viennot S, Cholet F, Nachury M, Flamant M, Reimund JM, Desfourneaux V, Boureille A, Siproudhis L, GETAID (Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives).
    Clin Gastroenterol Hepatol; 2020 Mar 21; 18(3):628-636. PubMed ID: 31128337
    [Abstract] [Full Text] [Related]

  • 14. Palliative treatment of anal fistulas in Crohn's disease.
    Hermann J, Eder P, Banasiewicz T, Kołodziejczak B, Łykowska-Szuber L.
    ANZ J Surg; 2016 Mar 21; 86(3):148-51. PubMed ID: 26861622
    [Abstract] [Full Text] [Related]

  • 15. Effect of a concomitant elemental diet with maintenance anti-tumor necrosis factor-α antibody therapy in patients with Crohn's disease: A multicenter, prospective cohort study.
    Hirai F, Ishida T, Takeshima F, Yamamoto S, Yoshikawa I, Ashizuka S, Inatsu H, Mitsuyama K, Sou S, Iwakiri R, Nozaki R, Ohi H, Esaki M, Iida M, Matsui T, Additional Power of Elemental Diet on Maintenance Biologics Therapy in Crohn's Disease (ADORE) Study Group.
    J Gastroenterol Hepatol; 2019 Jan 21; 34(1):132-139. PubMed ID: 29935082
    [Abstract] [Full Text] [Related]

  • 16. Fourteen-Year Anti-TNF Therapy in Crohn's Disease Patients: Clinical Characteristics and Predictive Factors.
    Osamura A, Suzuki Y.
    Dig Dis Sci; 2018 Jan 21; 63(1):204-208. PubMed ID: 29209921
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn's disease--clinical observations from a tertiary Eastern European center.
    Bor R, Farkas K, Bálint A, Szucs M, Ábrahám S, Baradnay G, Wittmann T, Szepes Z, Nagy F, Molnár T.
    Scand J Gastroenterol; 2015 Feb 21; 50(2):182-7. PubMed ID: 25384713
    [Abstract] [Full Text] [Related]

  • 18. Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience.
    Peyrin-Biroulet L, Salleron J, Filippi J, Reenaers C, Antunes O, Filipe V, Louis E, Hébuterne X, Roblin X.
    J Crohns Colitis; 2016 May 21; 10(5):516-24. PubMed ID: 26802084
    [Abstract] [Full Text] [Related]

  • 19. Intravenous Versus Subcutaneous Anti-TNF-Alpha Agents for Crohn's Disease: A Comparison of Effectiveness and Safety.
    Liu J, Sylwestrzak G, Ruggieri AP, DeVries A.
    J Manag Care Spec Pharm; 2015 Jul 21; 21(7):559-66. PubMed ID: 26108380
    [Abstract] [Full Text] [Related]

  • 20. Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn's Perianal Fistulas.
    De Gregorio M, Lee T, Krishnaprasad K, Amos G, An YK, Bastian-Jordan M, Begun J, Borok N, Brown DJM, Cheung W, Connor SJ, Gerstenmaier J, Gilbert LE, Gilmore R, Gu B, Kutaiba N, Lee A, Mahy G, Srinivasan A, Thin L, Thompson AJ, Welman CJ, Yong EXZ, De Cruz P, van Langenberg D, Sparrow MP, Ding NS.
    Clin Gastroenterol Hepatol; 2022 Jun 21; 20(6):1306-1314. PubMed ID: 34389484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.